Citrullinated Histone H3 (human recombinant)

Citrullinated Histone H3 (human recombinant) Suppliers list
Company Name: ChemeGen(Shanghai) Biotechnology Co.,Ltd.  
Tel: 18818260767
Email: sales@chemegen.com
Company Name: Shanghai Universal Biotech Co.,Ltd  
Tel: 15921930842 15921930842
Email: yh-wang@univ-bio.com
Citrullinated Histone H3 (human recombinant) Basic information
Product Name:Citrullinated Histone H3 (human recombinant)
Synonyms:Citrullinated Histone H3 (human recombinant)
CAS:
MF:
MW:0
EINECS:
Product Categories:
Mol File:Mol File
Citrullinated Histone H3 (human recombinant) Structure
Citrullinated Histone H3 (human recombinant) Chemical Properties
Safety Information
MSDS Information
Citrullinated Histone H3 (human recombinant) Usage And Synthesis
DescriptionA nucleosome is the basic repeating unit of chromatin in which 146 base pairs of DNA wrap twice around a histone octamer consisting of two copies of each of the core histones, H2A, H2B, H3, and H4. The combination of two H2A/H2B dimers and one H3/H4 tetramer create the nucleosome core. Histone H3 undergoes many modifications which include acetylation, methylation, and phosphorylation that are important for regulation of gene transcription. Citrullination is another important post-translational modification that is catalyzed by peptidylarginine deiminase 4 (PAD4) and PAD2. Hypercitrullination of histones leads to the development of neutrophil extracellular traps (NETs), which are a part of the inflammatory response. Neutrophils release these NETs to trap and eradicate bacteria and fungi. Failure to clear citrullinated proteins and NET components following inflammation can result in the production of autoantibodies and anti-citrullinated protein antibodies. The persistence of these antibodies and citrullinated proteins is associated with a number of human diseases including rheumatoid arthritis, systemic lupus erythematosus, Alzheimer’s disease, and multiple sclerosis. This product contains purified Histone H3 (human, recombinant) that has been modified with PAD4 enzyme, which is removed by affinity chromatography after the reaction.
References[1] YAN-MING XU  Andy T Y L  Ji Ying Du. Posttranslational modifications of human histone H3: An update[J]. Proteomics, 2014, 14 17-18: 2047-2060. DOI: 10.1002/pmic.201300435
[2] MD Y L, PHD  Zhengcai L M, PHD , et al. Citrullinated histone H3: A novel target for the treatment of sepsis[J]. Surgery, 2014, 156 2: Pages 229-234. DOI: 10.1016/j.surg.2014.04.009
[3] MARIO A. MOSCARELLO  D. D W  Fabrizio G Mastronardi. The Role of Citrullinated Proteins Suggests a Novel Mechanism in the Pathogenesis of Multiple Sclerosis[J]. Neurochemical Research, 2006, 32 2: 251-256. DOI: 10.1007/s11064-006-9144-5
[4] G MCNEE. Citrullination of histone H3 drives IL-6 production by bone marrow mesenchymal stem cells in MGUS and multiple myeloma[J]. Leukemia, 2016, 31 2: 373-381. DOI: 10.1038/leu.2016.187
[5] RANU SUROLIA. NETosis in the pathogenesis of acute lung injury following cutaneous chemical burns.[J]. JCI insight, 2021. DOI: 10.1172/jci.insight.147564
Citrullinated Histone H3 (human recombinant) Preparation Products And Raw materials
Tag:Citrullinated Histone H3 (human recombinant) Related Product Information
Histone H3 (Citrullinated R2 + R8 + R17) Monoclonal Antibody (Clone 11D3) Histone H3 (Citrullinated R2 + R8 + R17) Recombinant Monoclonal Antibody Citrullinated Histone H4 (human, recombinant)